Pharmaceuticals (Oct 2019)

Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome—Review of Classical and New Compounds: Part-I

  • Raquel Vieira,
  • Selma B. Souto,
  • Elena Sánchez-López,
  • Ana López Machado,
  • Patricia Severino,
  • Sajan Jose,
  • Antonello Santini,
  • Ana Fortuna,
  • Maria Luisa García,
  • Amelia M. Silva,
  • Eliana B. Souto

DOI
https://doi.org/10.3390/ph12040152
Journal volume & issue
Vol. 12, no. 4
p. 152

Abstract

Read online

Diabetes mellitus (DM) is a metabolic disorder characterized by chronic hyperglycemia together with disturbances in the metabolism of carbohydrates, proteins and fat, which in general results from an insulin availability and need imbalance. In a great number of patients, marketed anti-glycemic agents have shown poor effectiveness in maintaining a long-term glycemic control, thus being associated with severe adverse effects and leading to an emerging interest in natural compounds (e.g., essential oils and other secondary plant metabolites, namely, flavonoid-rich compounds) as a novel approach for prevention, management and/or treatment of either non-insulin-dependent diabetes mellitus (T2DM, type 2 DM) and/or Metabolic Syndrome (MS). In this review, some of these promising glucose-lowering agents will be comprehensively discussed.

Keywords